Irinotecan Hydrochloride
Product Images NDC 72485-212

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 72485-212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Fig3)

A survival curve comparing second-line Irinotecan versus Best Supportive Care (BSC) from Study 7. The graph plots probability on the y-axis and months on the x-axis, showing higher survival probability for Irinotecan over BSC. Median follow-up and median survival months are noted for each group, with a p-value indicating statistical significance.*

FDA Label Image

Image Description (Fig4)

A survival curve chart titled 'Survival Second-Line Irinotecan vs Infusion 5-FU Study 8' comparing probability of survival over 21 months between Irinotecan and 5-FU treatments. The chart shows survival probabilities on the vertical axis and months on the horizontal axis, with annotations indicating patient numbers, median follow-up, and median survival times for each treatment group, including a p-value from a log-rank test.*

FDA Label Image

Image Description (Label)

Label for Irinotecan Hydrochloride Injection USP 100 mg/5 mL (20 mg/mL) by Armas Pharmaceuticals Inc. Contains 5 mL single-dose vial for intravenous use. The sterile, aqueous solution includes irinotecan hydrochloride, sorbitol powder, lactic acid, and water for injection. The label advises storage at 20° to 25°C, protection from light and freezing, and notes it is a cytotoxic agent.*

FDA Label Image

Image Description (Structure)

Chemical structure of irinotecan hydrochloride trihydrate, the active ingredient in Irinotecan Hydrochloride 100 mg/5 mL by Armas Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.